Chatzimanolis, N., J. Kraus, R. Bauer, B. Engelhardt, T. Bregenzer, B. S. Kuehne, J. Tofighi, C. Laske, E. Stolz, F. Blaes, K. Voigt, H. Traupe, M. Kaps and P. Oschmann: CD45RA+ ICAM-3+ lymphocytes in interferon-beta 1b-treated and -untreated patients with relapsing-remitting multiple sclerosis.. In: Acta Neurologica Scandinavica 110, 6, 377-385 (2004).
doi: 10.1111/j.1600-0404.2004.00346.x
Kraus, J., R. Bauer, N. Chatzimanolis, B. Engelhardt, J. Tofighi, T. Bregenzer, B. Kuehne, E. Stolz, F. Blaes, K. Morgen, H. Traupe, M. Kaps and P. Oschmann: Interferon-beta 1b leads to a short-term increase of soluble but long-term stabilisation of cell surface bound adhesion molecules in multiple sclerosis.. In: Journal of Neurology 251, 4, 464-472 (2004).
Kraus, J., B. Engelhardt, N. Chatzimanolis, R. Bauer, J. Tofighi, B. S. Kuehne, C. Laske, E. Stolz, P. Frielinghaus, C. Schaefer, F. Blaes, H. Traupe, M. Kaps and P. Oschmann: Cell surface bound and soluble adhesion molecules in CSF and blood in multiple sclerosis: correlation with MRI-measures of subclinical disease severity and activity. In: J Neuroimmunol 122, 1-2, 175-185 (2002).
url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11777557
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.